3CMH
SYNTHETIC LINEAR TRUNCATED ENDOTHELIN-1 AGONIST
3CMH の概要
エントリーDOI | 10.2210/pdb3cmh/pdb |
関連するPDBエントリー | 6CMH |
分子名称 | PROTEIN (ENDOTHELIN-1) (1 entity in total) |
機能のキーワード | vasoconstrictor, endothelin-1, contractile protein |
細胞内の位置 | Secreted: P22388 |
タンパク質・核酸の鎖数 | 1 |
化学式量合計 | 1881.20 |
構造登録者 | Hewage, C.M.,Jiang, L.,Parkinson, J.A.,Ramage, R.,Sadler, I.H. (登録日: 1998-09-03, 公開日: 1999-09-29, 最終更新日: 2023-12-27) |
主引用文献 | Hewage, C.M.,Jiang, L.,Parkinson, J.A.,Ramage, R.,Sadler, I.H. Solution structure of a novel ETB receptor selective agonist ET1-21 [Cys(Acm)1,15, Aib3,11, Leu7] by nuclear magnetic resonance spectroscopy and molecular modelling. J.Pept.Res., 53:223-233, 1999 Cited by PubMed Abstract: The solution structure of a biologically active modified linear endothelin-1 analogue, ET1-21[Cys(Acm)1,15, Aib3,11, Leu7], has been determined for the first time by two-dimensional nuclear magnetic resonance spectroscopy in a methanol-d3/water solvent mixture. Out of approximately one hundred linear peptide analogues tested by biological assay, this peptide, together with a dozen others, showed significant ETB selective agonist activity. Here we report the solution structure of an ETB selective agonist of a full-length, synthetic linear endothelin analogue. The calculated structures indicate that the peptide adopts an alpha-helical conformation between residues Ser5-His16, whilst both N- and C-termini show no preferred conformation. These results suggest that the disulphide bridges normally associated with endothelin and sarafotoxin peptides may not necessarily be important for either ETB receptor binding activity or the formation of a helical conformation in solution. PubMed: 10231710DOI: 10.1034/j.1399-3011.1999.00001.x 主引用文献が同じPDBエントリー |
実験手法 | SOLUTION NMR |
構造検証レポート
検証レポート(詳細版)
をダウンロード
